Sodium Benzoate

苯甲酸钠

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameSodium Benzoate
Drug Alias Name安息香酸钠E-211
ClassificationSmall molecules
Mechanisms of ActionD-amino-acid oxidase inhibitors
TargetsD-amino-acid oxidase
Therapy Area/IndicationsSchizophreniaPsychotic DisordersHyperammonemia +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPakistanFinlandMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsHyperammonemiaMycosesBacterial Infections
Inactive IndicationsSchizophreniaPsychotic Disorders

Other Information

ATC CodeA16AX11
Related LinksWikipediaKEGG